Pharma Mar SA
Alain Rodriguez, Pharm.D. has extensive experience in the pharmaceutical industry, currently serving as Group Head of Corporate Regulatory Affairs at PharmaMar since January 2011, where responsibilities include overseeing regulatory compliance and strategy. Prior to this role, Alain held the position of DRA Manager for Neurosciences at Novartis from March 2006 to June 2010. Educational qualifications include studies at College-Lycée La Fontaine in Paris, Facultad de Farmacia in Salamanca, and Faculté de Pharmacie de Paris XI in Chatenay Malabry.
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.